Who
Frank A. Damelio
Director
Company insider
Files Form 4 as: Director, Zoetis; Director, Hewlett Packard Enterprise; Director, Viatris; Director, Humana; Director, Catalent; Executive Vice President, Pfizer; Chief Operating Officer, Lucent Technologies.
In numbers
- Trades disclosed
- 564
- Buys
- 4
- Sells
- 13
- Bought
- $1.3M
- Sold
- $40.5M
- Companies
- 7
- Companies where not an officer
- 5
- First trade
- 3 Jan 2006
- Last trade
- 7 Aug 2026
- Last filed
- 11 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Aug 2026filed 11 Aug 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code G | —6,650 at $0.00 | filing |
| 7 Aug 2026filed 11 Aug 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code G | —6,650 at $0.00 | filing |
| 13 May 2026filed 13 May 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Bought | $501K6,650 at $75.39 | filing |
| 13 May 2026filed 13 May 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Bought | $501K6,650 at $75.39 | filing |
| 1 May 2026filed 5 May 2026 | HPE Hewlett Packard Enterpriseoption or derivative · Hardware, Devices & Storage | SEC FORM 4 Code A | —8,750 | filing |
| 1 May 2026filed 5 May 2026 | HPE Hewlett Packard Enterpriseoption or derivative · Hardware, Devices & Storage | SEC FORM 4 Code A | —8,750 | filing |
| 1 Apr 2026filed 3 Apr 2026 | HPE Hewlett Packard EnterpriseHardware, Devices & Storage | SEC FORM 4 Code M | $348K14,499.052 at $23.98 | filing |
| 1 Apr 2026filed 3 Apr 2026 | HPE Hewlett Packard Enterpriseoption or derivative · Hardware, Devices & Storage | SEC FORM 4 Code M | —14,499.052 | filing |
| 1 Apr 2026filed 3 Apr 2026 | HPE Hewlett Packard Enterpriseoption or derivative · Hardware, Devices & Storage | SEC FORM 4 Code M | —14,499.05 | filing |
| 1 Apr 2026filed 3 Apr 2026 | HPE Hewlett Packard EnterpriseHardware, Devices & Storage | SEC FORM 4 Code M | $348K14,499.05 at $23.98 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS ViatrisPharmaceuticals | SEC FORM 4 Code M | —25,112 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS ViatrisPharmaceuticals | SEC FORM 4 Code M | —919 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —25,112 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —25,112 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —918.46 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —15,890 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —918.455 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —15,890 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS ViatrisPharmaceuticals | SEC FORM 4 Code M | —25,112 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS ViatrisPharmaceuticals | SEC FORM 4 Code M | —919 at $0.00 | filing |
The newest 500 lines are listed; the numbers count every line.
News
ZTS - Zoetis Inc Class A AnalysisZTS · morningstar.com · 12 Oct 2026
0 headlines in the last 90 days name Frank A. Damelio; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.